Strategies to adapt adenoviral vectors for targeted delivery.
about
Development of Adenoviral Delivery Systems to Target Hepatic Stellate Cells In VivoPhage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.Recombinant antibodies: a novel approach to cancer diagnosis and therapy.Radiation-guided gene therapy of cancer.Adenoviral vector immunity: its implications and circumvention strategies.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancerHIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.Current issues and future directions of oncolytic adenoviruses.A recombinant adenovirus-based vector elicits a specific humoral immune response against the V3 loop of HIV-1 gp120 in mice through the "Antigen Capsid-Incorporation" strategy.The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol.Replicative adenoviruses for cancer therapy.Current status of gene therapy for cystic fibrosis pulmonary disease.Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.In situ gene therapy for prostate cancer: immunomodulatory approaches.Current strategies and future directions for eluding adenoviral vector immunityPharmacotherapy for biochemical recurrences after therapy for localised prostate cancer.Delivery systems for pulmonary gene therapy.A Genetically Modified Adenoviral Vector with a Phage Display-Derived Peptide Incorporated into Fiber Fibritin Chimera Prolongs Survival in Experimental Glioma.Poliovirus receptor CD155-targeted oncolysis of gliomaConditionally replicative adenovirus for gastrointestinal cancers.Light-directed gene delivery by photochemical internalisation.HDAC inhibitor valproic acid upregulates CAR in vitro and in vivo.A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumorsGene therapy vector design strategies for the treatment of cancer.Herpes simplex virus 1 (HSV-1) for cancer treatment.Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomesCapsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach.Adenovirus fiber shaft contains a trimerization element that supports peptide fusion for targeted gene delivery.Oncolytic virus therapy for cancer.Oncolytic adenoviruses: design, generation, and experimental procedures.Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir.Novel subventricular zone early progenitor cell-specific adenovirus for in vivo therapy of central nervous system disorders reinforces brain stem cell heterogeneity.Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles.Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob.Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase.Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met.Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors.
P2860
Q28534124-03D87B4A-486F-4098-974F-E916C7D8F88EQ30685512-8A75F8A6-9683-432A-B833-B196A3C11948Q33181384-D65BD969-1E49-4738-99B3-6C46C671D700Q33251692-DF2690D3-E613-474E-87C1-23476FBF393EQ33565630-70285F58-6631-4D1A-9181-459E7F73FD68Q33584756-30C1FD8A-4E28-40A6-9107-66265C8A5830Q33646773-23376F28-5573-4203-87B6-CCE945BE5E0CQ33730705-4D7C211F-6261-48AE-B4E3-4BB10C0FFE0AQ33786140-D7532025-38DF-44EC-A9AD-A77187DE71EDQ33809074-870993EC-701C-4704-9D8F-E05899B7594CQ33963944-86ED096D-4222-42F7-82A7-86921DE1442FQ33975113-5E81CFA1-8AB4-4DBC-AEE7-8F293FC77C82Q34342665-7C070EAD-55C6-4358-BD31-26AA875EF750Q34452001-82EE7377-3357-4BE2-A0EB-6CE1AFB0EDBAQ34585554-3B384209-9273-4898-A918-29F6D1B472D6Q34660732-7886DEAB-D1B1-4354-AE37-8B5F17951835Q35627914-5CC70EA8-812C-4511-A5F4-8672AD2CFB72Q35658592-77F5E991-7517-480C-993C-9C67B4A8368AQ35800762-390061B4-D1D1-49A5-8D79-764B9F79C7D3Q35842604-79E486BE-7EE6-4F26-9EA5-92276F30E284Q35873756-67150CA1-1642-4039-9E65-679A781F40B7Q36326779-AE98994F-6AD6-41B1-BED8-B74CB2C60836Q36367252-33E24857-B29B-4AB7-9970-9451DD0CCB28Q36429492-19E99CEA-FFCC-4AD4-A79E-40A60DB3E8B3Q36444443-4FE357AC-5BC4-4C50-9711-9703E287AE37Q36713632-8FC71450-DC2D-431B-816F-848931A3AAD3Q37806749-C9856DA1-F13A-4FDB-8416-CDDE3BECB769Q38308865-A2E9A2DE-414A-43B0-8CA7-03A4BF19D9A3Q38924529-BFC5F510-1B0A-4D5D-A410-46EC1083982FQ39125899-B15F2EA0-C841-4692-B28D-EA7AC53BB262Q40459504-A0D1BF96-3AD2-498B-A605-9346AFB1257BQ40514543-43FC38E2-6A5B-4EE5-A152-434B8D8E21CFQ40561051-28AA7C6B-D3F4-40CD-8497-95E268A01B8EQ42155660-8DC2BAE2-FD38-475A-9229-4678E95D5373Q43724127-1CC0F5FA-2FFF-4B88-88ED-66D51089B24BQ44283779-039A2F5B-4EB2-4BAE-8964-AB9E7A0490DCQ45119726-E41907BC-37F9-4CFE-8271-6ED6ADCB6A3BQ45863319-C4DE60DE-AAAA-4779-886D-B716FFF8AAB7Q45870062-2D815383-9225-4BF1-B05D-0587F0EF627DQ45880080-95AD92F4-E0EA-4A33-B590-6F6222F20FD8
P2860
Strategies to adapt adenoviral vectors for targeted delivery.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Strategies to adapt adenoviral vectors for targeted delivery.
@ast
Strategies to adapt adenoviral vectors for targeted delivery.
@en
type
label
Strategies to adapt adenoviral vectors for targeted delivery.
@ast
Strategies to adapt adenoviral vectors for targeted delivery.
@en
prefLabel
Strategies to adapt adenoviral vectors for targeted delivery.
@ast
Strategies to adapt adenoviral vectors for targeted delivery.
@en
P2860
P1476
Strategies to adapt adenoviral vectors for targeted delivery.
@en
P2860
P304
P356
10.1111/J.1749-6632.1999.TB09409.X
P407
P577
1999-01-01T00:00:00Z